Lambert, S. A. et al. The human transcription factors. Cell 172, 650–665 (2018).
Medvedeva, Y. A. et al. EpiFactors: a comprehensive database of human epigenetic factors and complexes. Database 2015, bav067 (2015).
Göös, H. et al. Human transcription factor protein interaction networks. Nat. Commun. 13, 766 (2022).
Perez-Pinera, P. et al. RNA-guided gene activation by CRISPR–Cas9-based transcription factors. Nat. Methods 10, 973–976 (2013).
Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442–451 (2013).
Mali, P. et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31, 833–838 (2013).
Sanson, K. R. et al. Optimized libraries for CRISPR–Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 5416 (2018).
Gao, Y. et al. Complex transcriptional modulation with orthogonal and inducible dCas9 regulators. Nat. Methods 13, 1043–1049 (2016).
Soto, L. F. et al. Compendium of human transcription factor effector domains. Mol. Cell 82, 514–526 (2021).
Beerli, R. R., Segal, D. J., Dreier, B. & Barbas, C. F. 3rd Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc. Natl Acad. Sci. USA 95, 14628–14633 (1998).
Joung, J. et al. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood. Nature 548, 343–346 (2017).
Rivera, V. M. et al. A humanized system for pharmacologic control of gene expression. Nat. Med. 2, 1028–1032 (1996).
Hilton, I. B. et al. Epigenome editing by a CRISPR–Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 33, 510–517 (2015).
Fulco, C. P. et al. Systematic mapping of functional enhancer–promoter connections with CRISPR interference. Science 354, 769–773 (2016).
Segal, D. J. et al. Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor. J. Biol. Chem. 279, 14509–14519 (2004).
Bailus, B. J. et al. Protein delivery of an artificial transcription factor restores widespread Ube3a expression in an Angelman syndrome mouse brain. Mol. Ther. 24, 548–555 (2016).
Thakore, P. I. et al. RNA-guided transcriptional silencing in vivo with S. aureus CRISPR–Cas9 repressors. Nat. Commun. 9, 1674 (2018).
O’Geen, H. et al. dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression. Nucleic Acids Res. 45, 9901–9916 (2017).
Amabile, A. et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167, 219–232 (2016).
Hathaway, N. A. et al. Dynamics and memory of heterochromatin in living cells. Cell 149, 1447–1460 (2012).
Ying, Y. et al. The Krüppel-associated box repressor domain induces reversible and irreversible regulation of endogenous mouse genes by mediating different chromatin states. Nucleic Acids Res. 43, 1549–1561 (2015).
O’Geen, H., Tomkova, M., Combs, J. A., Tilley, E. K. & Segal, D. J. Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing. Nucleic Acids Res. 50, 3239–3253 (2022).
Cano-Rodriguez, D. et al. Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner. Nat. Commun. 7, 12284 (2016).
Hong, C. K. Y. & Cohen, B. A. Genomic environments scale the activities of diverse core promoters. Genome Res. 32, 85–96 (2022).
Sahu, B. et al. Sequence determinants of human gene regulatory elements. Nat. Genet. 54, 283–294 (2022).
O’Geen, H. et al. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner. Epigenetics Chromatin 12, 26 (2019).
Nuñez, J. K. et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell 184, 2503–2519 (2021).
Kearns, N. A. et al. Functional annotation of native enhancers with a Cas9–histone demethylase fusion. Nat. Methods 12, 401–403 (2015).
Cano-Rodriguez, D. & Rots, M. G. Epigenetic editing: on the verge of reprogramming gene expression at will. Curr. Genet. Med. Rep. 4, 170–179 (2016).
Sanborn, A. L. et al. Simple biochemical features underlie transcriptional activation domain diversity and dynamic, fuzzy binding to Mediator. eLife 10, e68068 (2021).
Arnold, C. D. et al. A high‐throughput method to identify trans‐activation domains within transcription factor sequences. EMBO J. 37, e98896 (2018).
Tycko, J. et al. High-throughput discovery and characterization of human transcriptional effectors. Cell 183, 2020–2035 (2020).
Alerasool, N., Leng, H., Lin, Z.-Y., Gingras, A.-C. & Taipale, M. Identification and functional characterization of transcriptional activators in human cells. Mol. Cell 82, 677–695 (2022).
DelRosso, N. et al. Large-scale mapping and mutagenesis of human transcriptional effector domains. Nature 616, 365–372 (2023).
Choi, S. H. et al. DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. Nucleic Acids Res. 44, 5161–5173 (2016).
Alfert, A., Moreno, N. & Kerl, K. The BAF complex in development and disease. Epigenetics Chromatin 12, 19 (2019).
Treich, I., Cairns, B. R., de los Santos, T., Brewster, E. & Carlson, M. SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2. Mol. Cell. Biol. 15, 4240–4248 (1995).
Childs, K. S. & Goodbourn, S. Identification of novel co‐repressor molecules for interferon regulatory factor‐2. Nucleic Acids Res. 31, 3016–3026 (2003).
Gnanapragasam, M. N. et al. p66α-MBD2 coiled-coil interaction and recruitment of Mi-2 are critical for globin gene silencing by the MBD2–NuRD complex. Proc. Natl Acad. Sci. USA 108, 7487–7492 (2011).
Yeo, N. C. et al. An enhanced CRISPR repressor for targeted mammalian gene regulation. Nat. Methods 15, 611–616 (2018).
Robinson, A. K. et al. The growth-suppressive function of the polycomb group protein polyhomeotic is mediated by polymerization of its sterile α motif (SAM) domain. J. Biol. Chem. 287, 8702–8713 (2012).
Chen, K., Ou, X.-M., Chen, G., Choi, S. H. & Shih, J. C. R1, a novel repressor of the human monoamine oxidase A. J. Biol. Chem. 280, 11552–11559 (2005).
McIsaac, R. S., Petti, A. A., Bussemaker, H. J. & Botstein, D. Perturbation-based analysis and modeling of combinatorial regulation in the yeast sulfur assimilation pathway. Mol. Biol. Cell 23, 2993–3007 (2012).
Ledent, V., Paquet, O. & Vervoort, M. Phylogenetic analysis of the human basic helix–loop–helix proteins. Genome Biol. 3, RESEARCH0030 (2002).
Atchley, W. R. & Fitch, W. M. A natural classification of the basic helix–loop–helix class of transcription factors. Proc. Natl Acad. Sci. USA 94, 5172–5176 (1997).
Torres-Machorro, A. L. Homodimeric and heterodimeric interactions among vertebrate basic helix–loop–helix transcription factors. Int. J. Mol. Sci. 22, 12855 (2021).
Tycko, J. et al. Mitigation of off-target toxicity in CRISPR–Cas9 screens for essential non-coding elements. Nat. Commun. 10, 4063 (2019).
Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J. & Pavletich, N. P. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A–Cdk2 complex. Nature 382, 325–331 (1996).
Kubota, H. Quality control against misfolded proteins in the cytosol: a network for cell survival. J. Biochem. 146, 609–616 (2009).
Thakore, P. I. et al. Highly specific epigenome editing by CRISPR–Cas9 repressors for silencing of distal regulatory elements. Nat. Methods 12, 1143–1149 (2015).
Alerasool, N., Segal, D., Lee, H. & Taipale, M. An efficient KRAB domain for CRISPRi applications in human cells. Nat. Methods 17, 1093–1096 (2020).
Replogle, J. M. et al. Mapping information-rich genotype–phenotype landscapes with genome-scale Perturb-seq. Cell 185, 2559–2575 (2022).
Tak, Y. E. et al. Inducible and multiplex gene regulation using CRISPR–Cpf1-based transcription factors. Nat. Methods 14, 1163–1166 (2017).
Kleinstiver, B. P. et al. Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat. Biotechnol. 37, 276–282 (2019).
Replogle, J. M. et al. Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors. eLife 11, e81856 (2022).
Gemberling, M. P. et al. Transgenic mice for in vivo epigenome editing with CRISPR-based systems. Nat. Methods 18, 965–974 (2021).
Karlsson, E. et al. Disordered regions flanking the binding interface modulate affinity between CBP and NCOA. J. Mol. Biol. 434, 167643 (2022).
Chen, H. et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90, 569–580 (1997).
Wang, F. et al. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment. Proc. Natl Acad. Sci. USA 109, 6078–6083 (2012).
Percharde, M. et al. Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev. 26, 2286–2298 (2012).
Eijkelenboom, A. et al. Genome-wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling. Mol. Syst. Biol. 9, 638 (2013).
Eijkelenboom, A., Mokry, M., Smits, L. M., Nieuwenhuis, E. E. & Burgering, B. M. T. FOXO3 selectively amplifies enhancer activity to establish target gene regulation. Cell Rep. 5, 1664–1678 (2013).
Maeder, M. L. et al. CRISPR RNA-guided activation of endogenous human genes. Nat. Methods 10, 977–979 (2013).
Chavez, A. et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12, 326–328 (2015).
Tanenbaum, M. E., Gilbert, L. A., Qi, L. S., Weissman, J. S. & Vale, R. D. A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159, 635–646 (2014).
Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR–Cas9 complex. Nature 517, 583–588 (2015).
Zhou, H. et al. In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR–dCas9-activator transgenic mice. Nat. Neurosci. 21, 440–446 (2018).
Dominguez, A. A. et al. CRISPR-mediated synergistic epigenetic and transcriptional control. CRISPR J. 5, 264–275 (2022).
Counsell, J. R. et al. Lentiviral vectors can be used for full-length dystrophin gene therapy. Sci. Rep. 7, 44775 (2017).
Ptashne, M. & Gann, A. A. F. Activators and targets. Nature 346, 329–331 (1990).
Sadowski, I., Ma, J., Triezenberg, S. & Ptashne, M. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563–564 (1988).
Jones, R. D. et al. An endoribonuclease-based feedforward controller for decoupling resource-limited genetic modules in mammalian cells. Nat. Commun. 11, 5690 (2020).
Wang, K. et al. Systematic comparison of CRISPR-based transcriptional activators uncovers gene-regulatory features of enhancer–promoter interactions. Nucleic Acids Res. 50, 7842–7855 (2022).
Mahata, B. et al. Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control. Nat. Methods 20, 1716–1728 (2023).
Guo, L. Y. et al. Multiplexed genome regulation in vivo with hyper-efficient Cas12a. Nat. Cell Biol. 24, 590–600 (2022).
Xu, X. et al. Engineered miniature CRISPR–Cas system for mammalian genome regulation and editing. Mol. Cell 81, 4333–4345 (2021).
Bhatt, B., García-Díaz, P. & Foight, G. W. Synthetic transcription factor engineering for cell and gene therapy. Trends Biotechnol. 42, 449–463 (2023).
Pomerantz, J. L., Sharp, P. A. & Pabo, C. O. Structure-based design of transcription factors. Science 267, 93–96 (1995).
Rivera, V. M. et al. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 105, 1424–1430 (2005).
Suzumura, K. et al. Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in mice. Hepatol. Int. 2, 80–88 (2008).
Schievenbusch, S. et al. Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis. Mol. Ther. 18, 1302–1309 (2010).
Lee, S. H. et al. Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models. Acta Neuropathol. Commun. 7, 96 (2019).
Matsuda, E., Obama, Y. & Kosai, K.-I. Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice. Life Sci. 268, 119014 (2021).
Morishita, R. et al. Combined analysis of clinical data on HGF gene therapy to treat critical limb ischemia in Japan. Curr. Gene Ther. 20, 25–35 (2020).
Li, H.-S. et al. Multidimensional control of therapeutic human cell function with synthetic gene circuits. Science 378, 1227–1234 (2022).
Jia, Y. et al. Next-generation CRISPR/Cas9 transcriptional activation in Drosophila using flySAM. Proc. Natl Acad. Sci. USA 115, 4719–4724 (2018).
Ewen-Campen, B. et al. Optimized strategy for in vivo Cas9-activation in Drosophila. Proc. Natl Acad. Sci. USA 114, 9409–9414 (2017).
Yamagata, T. et al. CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice. Neurobiol. Dis. 141, 104954 (2020).
Magnusson, J. P., Rios, A. R., Wu, L. & Qi, L. S. Enhanced Cas12a multi-gene regulation using a CRISPR array separator. eLife 10, e66406 (2021).
Griffith, A. L. et al. Optimization of Cas12a for multiplexed genome-scale transcriptional activation. Cell Genom. 3, 100387 (2023).
Hsiung, C. C.-S. et al. Engineered CRISPR–Cas12a for higher-order combinatorial chromatin perturbations. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02224-0 (2024).
Vora, S. et al. Rational design of a compact CRISPR–Cas9 activator for AAV-mediated delivery. Preprint at bioRxiv https://doi.org/10.1101/298620 (2018).
Ma, D., Peng, S., Huang, W., Cai, Z. & Xie, Z. Rational design of mini-Cas9 for transcriptional activation. ACS Synth. Biol. 7, 978–985 (2018).
Omachi, K. & Miner, J. H. Comparative analysis of dCas9–VP64 variants and multiplexed guide RNAs mediating CRISPR activation. PLoS ONE 17, e0270008 (2022).
Mukund, A. X. et al. High-throughput functional characterization of combinations of transcriptional activators and repressors. Cell Syst. 14, 746–763 (2023).
Ludwig, C. H. et al. High-throughput discovery and characterization of viral transcriptional effectors in human cells. Cell Syst. 14, 482–500 (2023).
Jacobs, J., Pagani, M., Wenzl, C. & Stark, A. Widespread regulatory specificities between transcriptional corepressors and enhancers in Drosophila. Science 381, 198–204 (2022).
Policarpi, C., Munafò, M., Tsagkris, S., Carlini, V. & Hackett, J. A. Systematic epigenome editing captures the context-dependent instructive function of chromatin modifications. Nat. Genet. 56, 1168–1180 (2022).
Bedford, M. T., Chan, D. C. & Leder, P. FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. EMBO J. 16, 2376–2383 (1997).
Macias, M. J., Wiesner, S. & Sudol, M. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. FEBS Lett. 513, 30–37 (2002).
Gerber, H. P. et al. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263, 808–811 (1994).
Akhtar, W. et al. Using TRIP for genome-wide position effect analysis in cultured cells. Nat. Protoc. 9, 1255–1281 (2014).
Li, X. et al. Chromatin context-dependent regulation and epigenetic manipulation of prime editing. Cell 187, 2411–2427 (2024).
Velimirovic, M. et al. Peptide fusion improves prime editing efficiency. Nat. Commun. 13, 3512 (2022).
Haberle, V. et al. Transcriptional cofactors display specificity for distinct types of core promoters. Nature 570, 122–126 (2019).
Sanjana, N. E. et al. A transcription activator-like effector toolbox for genome engineering. Nat. Protoc. 7, 171–192 (2012).
UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 43, D204–D212 (2015).
Bakan, A., Meireles, L. M. & Bahar, I. ProDy: protein dynamics inferred from theory and experiments. Bioinformatics 27, 1575–1577 (2011).
Zulkower, V. & Rosser, S. DNA Chisel, a versatile sequence optimizer. Bioinformatics 36, 4508–4509 (2020).
Roney, I. J., Rudner, A. D., Couture, J.-F. & Kærn, M. Improvement of the reverse tetracycline transactivator by single amino acid substitutions that reduce leaky target gene expression to undetectable levels. Sci Rep. 6, 27697 (2016).
Tycko, J. HT-recruit-analyze. GitHub github.com/bintulab/HT-recruit-Analyze (2020).
Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinform. 18, 529 (2017).
Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).
Tycko J., et al. Development of compact transcriptional effectors using high-throughput measurements in diverse contexts. Datasets. NCBI Sequence Read Archive https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1160796 (2024).
Tycko J., et al. Development of compact transcriptional effectors using high-throughput measurements in diverse contexts. Datasets. Zenodo https://doi.org/10.5281/zenodo.13756269 (2024).
Morgens, D. W., Deans, R. M., Li, A. & Bassik, M. C. Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes. Nat. Biotechnol. 34, 634–636 (2016).
Leers, J., Treuter, E. & Gustafsson, J. A. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2. Mol. Cell. Biol. 18, 6001–6013 (1998).
UniProt Consortium UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506–D515 (2019).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Varadi, M. et al. AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439–D444 (2022).
Horlbeck, M. A. et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLife 5, e19760 (2016).
Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455–461 (2014).
